Manipal Health Enterprises Set to Launch Major IPO in India

Manipal Health Enterprises is on the verge of launching one of India's largest IPOs, potentially valued at $10 billion. Supported by Temasek Holdings, the company aims to reshape the healthcare landscape in 2026. With investor discussions completed and regulatory filings underway, all eyes are on whether this offering can reignite interest in the Indian IPO market, which has seen a slowdown this year. The proposed IPO includes a fresh issue of shares and a stake sale, marking a significant milestone for both the company and the capital markets.

By Narendra Chaudhary Jun 17, 2026, 18:20 IST

Upcoming IPO Could Be a Game Changer

Manipal Health Enterprises Pvt., which operates the Manipal Hospitals network, is gearing up for what might be one of the largest public offerings in India this year. A report from Bloomberg, citing sources familiar with the situation, suggests that the healthcare provider could initiate its initial public offering (IPO) as early as next month, marking a pivotal moment for both the company and the Indian capital markets.

Supported by Temasek Holdings, a Singapore-based investor, the hospital chain has reportedly concluded discussions with investors and is targeting a valuation of around $10 billion. If successful, this IPO could represent India's first billion-dollar offering of the year. This proposed listing comes at a crucial time when the domestic equity market is seeking renewed energy after a relatively slow start to 2026.

In the past two years, India's IPO market experienced unprecedented fundraising activity, but this year has seen a slowdown. So far in 2026, companies have raised approximately $3.6 billion through initial share sales, indicating a significant opportunity for a major transaction to rekindle investor enthusiasm.

While preparations are underway, final details are still being negotiated. Sources mentioned that the size, structure, and timing of the IPO could be adjusted before the company officially enters the market.

IPO Structure: Fresh Issue and Stake Sale

In March, Manipal Hospitals submitted its draft red herring prospectus to India's securities regulator, detailing the proposed transaction. The IPO is expected to feature a fresh issue of shares valued at approximately 80 billion rupees. Additionally, existing shareholders plan to sell up to 43.23 million shares, which accounts for about 3.66 percent of the company's equity.

This combination of new shares and secondary sales is anticipated to generate fresh capital for the company while allowing some investors to partially cash out their investments. To facilitate the public offering, Manipal Hospitals has partnered with several prominent financial institutions and investment banks. Key advisers involved in the potential listing include Kotak Mahindra Capital Co., Axis Capital Ltd., and the Indian branches of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Securities, and DBS Bank Ltd.

The participation of these major banking institutions underscores the significance and scale of the proposed transaction. Market observers will be keenly watching the healthcare provider's next steps as it prepares for a potential public debut that could become one of the most anticipated IPOs of the year. With investor meetings concluded and regulatory filings in place, all eyes are on whether Manipal Hospitals can successfully navigate a listing that may transform the landscape of India's healthcare and IPO sectors in 2026.